Therapeutic Benefits of Topical Omega‐3 Polyunsaturated Fatty Acids in Skin Diseases and Cosmetics: An Updated Systematic Review
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70341 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Laura Mateu-Arrom und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Universitat Autònoma de B…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Skin Diseases, Anti-Inflammatory Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oral supplementation with omega‐3 polyunsaturated fatty acids (ω‐3 PUFAs) has shown beneficial effects in some dermatologic diseases (i.e., atopic dermatitis, acne, psoriasis, burns), but the actual effect of local application of ω‐3 PUFAs for improving skin health is still under investigation.
Aims
This paper systematically reviewed the current articles regarding the use of topical ω‐3 PUFAs in the treatment of skin diseases to evaluate its efficacy and safety.
Methods
The review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta‐analysis (PRISMA) recommendations. Studies in which ω‐3 PUFAs were administered as oral treatments, those with a reduced or unknown ω‐3 PUFAs composition, and those using with skin fish grafts were excluded.
Results
In skin models of psoriasis, wounds, dermatitis, and melanoma, topical ω‐3 PUFAs showed an overall beneficial effect associated with the anti‐inflammatory properties of these compounds. Furthermore, none of the studies reported cases of skin irritation, cytotoxicity, or any adverse events.
Conclusions
The increasing number of studies conducted on topical treatments with ω‐3 PUFAs and the existing evidence suggest that ω‐3 PUFAs could be a promising option as an adjuvant or complementary treatment in managing several dermatological conditions. However, there is still a lack of consensus about the optimal dosage, molecules, or delivery methods of ω‐3 PUFAs; consequently, more clinical studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
- Brudy Technology, S.L., Barcelona, Spain.
- Universitat Rovira i Virgili, Tarragona, Spain.
- Brudy Lab S.L., Barcelona, Spain.
ORCID-Profile: Laura Mateu-Arrom, Ignasi Mora
Zitieren
APA
Mateu-Arrom, L., Mora, I., & Garrote, L. (2025). Therapeutic Benefits of Topical Omega‐3 Polyunsaturated Fatty Acids in Skin Diseases and Cosmetics: An Updated Systematic Review. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70341
Vancouver
Mateu-Arrom L, Mora I, Garrote L. Therapeutic Benefits of Topical Omega‐3 Polyunsaturated Fatty Acids in Skin Diseases and Cosmetics: An Updated Systematic Review. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70341
BibTeX
@article{MateuArrom2025,
author = {Mateu-Arrom, Laura and Mora, Ignasi and Garrote, Leia},
title = {Therapeutic Benefits of Topical Omega‐3 Polyunsaturated Fatty Acids in Skin Diseases and Cosmetics: An Updated Systematic Review},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70341}
}
EUVIMED